🇺🇸 FDA
Patent

US 9931377

Cell expressing complexes of IL-15 and IL-15Ralpha

granted A61KA61K2039/5152A61K2039/5156

Quick answer

US patent 9931377 (Cell expressing complexes of IL-15 and IL-15Ralpha) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Mar 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Apr 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K2039/5152, A61K2039/5156, A61K2039/55527, A61K35/13